<DOC>
	<DOC>NCT01552850</DOC>
	<brief_summary>To estimate the pharmacokinetics and relative bioavailability of oxycodone after administration of 40 mg doses of four PF-00345439 formulations and oxycodone in solution</brief_summary>
	<brief_title>Pharmacokinetics And Relative Bioavailability Study Of Oxycodone</brief_title>
	<detailed_description>This study will estimate the PK and relative bioavailability of oxycodone following single oral 40-mg doses of 3 modified PF-00345439 Formulations B, C, and D compared with the reference Formulation A under fed conditions.</detailed_description>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Healthy male and/or female subjects between the ages of 21 and 55 years, inclusive Evidence or history of clinically significant diseases</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>relative bioavailability</keyword>
	<keyword>oxycodone</keyword>
</DOC>